About Clinical Ink
Clinical Ink is a company based in Winston-salem (United States) founded in 2006 was acquired by GI Partners in August 2020.. Clinical Ink has raised $13.15 million across 8 funding rounds from investors including SVB, GI Partners and RTI International. Clinical Ink has completed 1 acquisition, including Digital Artefacts. Clinical Ink offers products and services including eCOA, Direct Data Capture, and eConsent. Clinical Ink operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Winston-salem, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Clinical Ink
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.15 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
SVB
& 8 more
-
Employee Count
Employee Count
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinical Ink
Clinical Ink offers a comprehensive portfolio of products and services, including eCOA, Direct Data Capture, and eConsent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for capturing and managing clinical trial outcomes electronically.
Software to validate real-time data from trials and devices.
System for simplifying electronic consent in clinical studies.
Unlock access to complete
Unlock access to complete
Software Development Team
22 people
Project Team
14 people
Leadership Team
11 people
Data Analysis and Operations Team
9 people
Creative and Marketing Team
5 people
Advisor Team
4 people
Product Management Team
4 people
Senior Team
4 people
Unlock access to complete
Funding Insights of Clinical Ink
Clinical Ink has successfully raised a total of $13.15M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Debt – Venture - Clinical Ink | Valuation |
investors |
|
| May, 2018 | Amount | Series C - Clinical Ink | Valuation |
investors |
|
| Jun, 2017 | Amount | Series C - Clinical Ink | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Clinical Ink
Clinical Ink has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, GI Partners and RTI International. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech-focused venture capital firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
VC investments are handled by the McWhorter family office.
|
Founded Year | Domain | Location | |
|
Offline-focused VC firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Clinical Ink
Clinical Ink has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Digital Artefacts. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of the clinical trial management platform
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Clinical Ink
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Clinical Ink Comparisons
Competitors of Clinical Ink
Clinical Ink operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| domain | founded_year | HQ Location |
AI-based solutions for health management are provided.
|
|
| domain | founded_year | HQ Location |
Clinical trial management software is provided for researchers and professionals.
|
|
| domain | founded_year | HQ Location |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| domain | founded_year | HQ Location |
Regulatory and ethical review services for clinical research are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Clinical Ink
Frequently Asked Questions about Clinical Ink
When was Clinical Ink founded?
Clinical Ink was founded in 2006.
Where is Clinical Ink located?
Clinical Ink is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Who is the current CEO of Clinical Ink?
Jonathan Goldman is the current CEO of Clinical Ink.
Is Clinical Ink a funded company?
Clinical Ink is a funded company, having raised a total of $13.15M across 8 funding rounds to date.
What does Clinical Ink do?
Clinical Ink was founded in 2006 and is headquartered in Winston-Salem, United States. eSource solutions are offered through the SureSource platform, which enables electronic capture of data and documents at clinical trial sites. The CentrosHealth platform supports patient engagement via configurable apps to maintain involvement and compliance. Services target pharmaceutical companies, medical device firms, academic institutions, and contract research organizations in the global clinical trials sector.
Who are the top competitors of Clinical Ink?
What products or services does Clinical Ink offer?
Clinical Ink offers eCOA, Direct Data Capture, and eConsent.
How many acquisitions has Clinical Ink made?
Clinical Ink has made 1 acquisition, including Digital Artefacts.
Who are Clinical Ink's investors?
Clinical Ink has 9 investors. Key investors include SVB, GI Partners, RTI International, SLR Investment Corp, and Dioko Ventures.